scholarly journals Rehabilitation of Lower Anteriors with Implant Therapy in Localized Aggressive Periodontitis

2017 ◽  
Vol 1 (1) ◽  
pp. 40-44
Author(s):  
Varshal J Barot
Keyword(s):  
Tooth Loss ◽  
Aggressive Periodontitis ◽  
Early Age ◽  
Viable Option ◽  
Implant Placement ◽  
History Of ◽  
Implant Therapy ◽  
Localized Aggressive Periodontitis ◽  
Rare Group ◽  
Severe Destruction

ABSTRACT Periodontitis is the most common, destructive, inflammatory disease of supporting tissues of the teeth in humans, with profound effects on general health. Aggressive periodontitis (AgP) comprises a rare group of population, a rapidly progressing form of periodontitis, characterized by severe destruction of periodontal attachment apparatus and tooth loss at an early age. Considering the psychological problems that these patients have faced during the early stages of their life, the main aim of treatment is to achieve functional, esthetic, and phonetic rehabilitation. Dental implant is a widely used treatment option that provides functional and esthetic resolution. Implant placement in patients with a history of AgP might be considered a viable option to restore oral function; however, the risk for implant failure is significantly higher. This report presents rehabilitation of lower anteriors with implant therapy in a 24-year-old systemically healthy male with history of localized AgP, who had previously received complete periodontal therapy for periodontal stabilization. How to cite this article Barot VJ. Rehabilitation of Lower Anteriors with Implant Therapy in Localized Aggressive Periodontitis. Int J Clin Dent Res 2017;1(1):40-44.

scholarly journals Rehabilitation of Lower Anterior Teeth with Implant Therapy in Localized Aggressive Periodontitis

2018 ◽  
Vol 9 (2) ◽  
pp. 63-68
Author(s):  
Varshal J Barot
Keyword(s):  
Tooth Loss ◽  
Inflammatory Diseases ◽  
Aggressive Periodontitis ◽  
Early Age ◽  
Viable Option ◽  
Implant Placement ◽  
Anterior Teeth ◽  
History Of ◽  
Implant Therapy ◽  
Severe Destruction

Periodontitis is the most common, destructive, inflammatory diseases of supporting tissues of the teeth in humans, with profound effects on general health. Aggressive periodontitis (AgP) comprises a rare, rapidly progressing form of periodontitis, characterized by severe destruction of periodontal attachment apparatus and tooth loss at an early age. Considering the psychological problems which these patients have during the early stages of their life, the chief aim of the treatment is to achieve functional, esthetic, and phonetic rehabilitation. Dental implant is a widely used treatment option that provides functional and esthetic resolution. Implant placement in patients with a history of AP might be considered a viable option to restore oral function; however, the risk for implant failure is significantly higher. This report presents rehabilitation of lower anterior teeth with implant therapy in a 24-year-old systemically healthy male with a history of localized AP, who had previously received complete periodontal therapy for periodontal stabilization

scholarly journals Management of Rapidly Progressing Periodontitis: An Overview

2017 ◽  
Vol 28 (1) ◽  
pp. 32-38
Author(s):  
SM Anwar Sadat ◽  
Naim Mahmud Chowdhury ◽  
Redwan Bin Abdul Baten
Keyword(s):  
Tissue Engineering ◽  
Tooth Loss ◽  
Periodontal Diseases ◽  
Aggressive Periodontitis ◽  
Regenerative Therapy ◽  
Successful Management ◽  
History Of ◽  
Rapid Destruction ◽  
Genetic Technologies ◽  
Early Tooth Loss

History of periodontal diseases recognition and treatment is ancient for at least 5000 years. There are different presentations of periodontal diseases. Rapidly progression periodontitis or aggressive periodontitis causes rapid destruction of the periodontium which leads to early tooth loss. It may be generalized or localized. Periodontitis may be treated surgically or non-surgically but patients with rapidly progressing periodontitis do not respond predictably to conventional therapy due to its multi factorial etiology. Successful management of the disease is difficult if not diagnosed early and treated appropriately. Regenerative therapy, tissue engineering and genetic technologies are the new hope for the treatment of rapidly progressing periodontitis.Medicine Today 2016 Vol.28(1): 32-38

Outcomes of implant therapy in patients with a history of aggressive periodontitis. A systematic review and meta-analysis

2016 ◽  
Vol 21 (2) ◽  
pp. 485-503 ◽  
Author(s):  
Charis Theodoridis ◽  
Andreas Grigoriadis ◽  
Georgios Menexes ◽  
Ioannis Vouros
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Aggressive Periodontitis ◽  
History Of ◽  
Implant Therapy

Dental Implant Placement in Patients with a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review

2020 ◽  
Author(s):  
Judd Sher ◽  
Kate Kirkham-Ali ◽  
Denny Luo ◽  
Catherine Miller ◽  
Dileep Sharma
Keyword(s):  
Systematic Review ◽  
At Risk ◽  
Drug Therapy ◽  
Dental Implant ◽  
Case Series ◽  
Cochrane Central Register ◽  
Bisphosphonate Treatment ◽  
Implant Placement ◽  
Increased Risk ◽  
History Of

The present systematic review evaluates the safety of placing dental implants in patients with a history of antiresorptive or antiangiogenic drug therapy. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed. PubMed, Cochrane Central Register of Controlled Trials, Scopus, Web of Science, and OpenGrey databases were used to search for clinical studies (English only) to July 16, 2019. Study quality was assessed regarding randomization, allocation sequence concealment, blinding, incomplete outcome data, selective outcome reporting, and other biases using a modified Newcastle-Ottawa scale and the Joanna Briggs Institute critical appraisal checklist for case series. A broad search strategy resulted in the identification of 7542 studies. There were 28 studies reporting on bisphosphonates (5 cohort, 6 case control, and 17 case series) and one study reporting on denosumab (case series) that met the inclusion criteria and were included in the qualitative synthesis. The quality assessment revealed an overall moderate quality of evidence among the studies. Results demonstrated that patients with a history of bisphosphonate treatment for osteoporosis are not at increased risk of implant failure in terms of osseointegration. However, all patients with a history of bisphosphonate treatment, whether taken orally for osteoporosis or intravenously for malignancy, appear to be at risk of ‘implant surgery-triggered’ MRONJ. In contrast, the risk of MRONJ in patients treated with denosumab for osteoporosis was found to be negligible. In conclusion, general and specialist dentists should exercise caution when planning dental implant therapy in patients with a history of bisphosphonate and denosumab drug therapy. Importantly, all patients with a history of bisphosphonates are at risk of MRONJ, necessitating this to be included in the informed consent obtained prior to implant placement. The James Cook University College of Medicine and Dentistry Honours program and the Australian Dental Research Foundation Colin Cormie Grant were the primary sources of funding for this systematic review.

scholarly journals COVID-19 in a Cohort of Patients with Congenital Myasthenic Syndrome

2021 ◽  
pp. 1-3
Author(s):  
Setareh Alabaf ◽  
Karen O'Connell ◽  
Sithara Ramdas ◽  
David Beeson ◽  
Jacqueline Palace
Keyword(s):  
High Risk ◽  
Neuromuscular Transmission ◽  
Genetic Disorders ◽  
Severe Disease ◽  
Congenital Myasthenic Syndrome ◽  
Referral Centre ◽  
History Of ◽  
Myasthenic Syndrome ◽  
The Uk ◽  
Rare Group

Congenital Myasthenic Syndrome (CMS) are a rare group of genetic disorders of neuromuscular transmission. Some subtypes of CMS can be associated with respiratory and bulbar weakness and these patients may therefore be at high risk of developing a severe disease from COVID-19. We screened 73 patients with genetically confirmed CMS who were attending the UK national referral centre for evidence of previous Severe Acute Respiratory Syndrome Corona Virus 2 infection and their clinical outcome. Of 73 patients, seven had history of confirmed COVID-19. None of the infected patients developed a severe disease, and there were no signals that CMS alone carries a high risk of severe disease from COVID-19.

TERATOMA OF THE NECK IN A NEWBORN INFANT

PEDIATRICS ◽  
1952 ◽  
Vol 9 (5) ◽  
pp. 565-571
Author(s):  
ROBERT R. WHITE ◽  
RUTH S. GOSSELIN
Keyword(s):  
Newborn Infant ◽  
Case History ◽  
Early Age ◽  
History Of

The case history of a three day old infant with a huge teratoma of the neck, endangering the infant's life and demanding immediate surgical attack, is presented. This report illustrates still another condition amenable to operative relief at an early age.

Sign in / Sign up

Export Citation Format

Share Document